These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 16343870
1. [Pharmacovigilance of vaccines]. Autret-Leca E, Bensouda-Grimaldi L, Jonville-Béra AP, Beau-Salinas F. Arch Pediatr; 2006 Feb; 13(2):175-80. PubMed ID: 16343870 [Abstract] [Full Text] [Related]
7. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database. Michenot F, Sommet A, Bagheri H, Lapeyre-Mestre M, Montastruc JL, French Network of PharmacoVigilance Centres. Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603 [Abstract] [Full Text] [Related]
8. Veterinary pharmacovigilance in the European context. Keck G. Ann Ist Super Sanita; 1992 Oct; 28(4):425-8. PubMed ID: 1303032 [Abstract] [Full Text] [Related]
9. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France. Olivier P, Montastruc JL. Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082 [Abstract] [Full Text] [Related]
10. Post-marketing surveillance of immediate allergic reactions: polygeline-based versus polygeline-free pediatric TBE vaccine. Zent O, Hennig R. Vaccine; 2004 Dec 16; 23(5):579-84. PubMed ID: 15542177 [Abstract] [Full Text] [Related]
12. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database. Durrieu G, Olivier P, Bagheri H, Montastruc JL, French Network of Pharmacovigilance Centers. Fundam Clin Pharmacol; 2007 Oct 16; 21(5):555-8. PubMed ID: 17868209 [Abstract] [Full Text] [Related]
13. [Pharmacovigilance off the beaten track: herbal surveillance or pharmacovigilance of medicinal plants]. Castot A, Djezzar S, Deleau N, Guillot B, Efthymiou ML. Therapie; 1997 Oct 16; 52(2):97-103. PubMed ID: 9231502 [Abstract] [Full Text] [Related]
14. Vaccinovigilance in Europe--need for timeliness, standardization and resources. Lankinen KS, Pastila S, Kilpi T, Nohynek H, Mäkelä PH, Olin P. Bull World Health Organ; 2004 Nov 16; 82(11):828-35. PubMed ID: 15640918 [Abstract] [Full Text] [Related]
15. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004. Nakayama T, Onoda K. Vaccine; 2007 Jan 05; 25(3):570-6. PubMed ID: 16945455 [Abstract] [Full Text] [Related]
16. [New methods for studying drug associated risk: experience of the Toulouse Regional Pharmacovigilance Center]. Montastruc JL, Bagheri H, Lacroix I, Olivier P, Durrieu G, Damase-Michel C, Lapeyre-Mestre M. Bull Acad Natl Med; 2005 Mar 05; 189(3):493-502; discussion 502-5. PubMed ID: 16149213 [Abstract] [Full Text] [Related]
17. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database. Shalviri G, Mohammad K, Majdzadeh R, Gholami K. Pharmacoepidemiol Drug Saf; 2007 Oct 05; 16(10):1136-40. PubMed ID: 17705214 [Abstract] [Full Text] [Related]
18. Nurses are increasingly involved in pharmacovigilance in Sweden. Ulfvarson J, Mejyr S, Bergman U. Pharmacoepidemiol Drug Saf; 2007 May 05; 16(5):532-7. PubMed ID: 17072915 [Abstract] [Full Text] [Related]
19. Adverse drug reactions in children in Camagüey Province, Cuba. Arencibia ZB, Sotomayor DN, Mollinedo NC, Choonara I, Manzano EF, Leyva AL. Arch Dis Child; 2010 Jun 05; 95(6):474-7. PubMed ID: 20501541 [Abstract] [Full Text] [Related]
20. Adverse drug reactions: a review of relevant factors. Ajayi FO, Sun H, Perry J. J Clin Pharmacol; 2000 Oct 05; 40(10):1093-101. PubMed ID: 11028248 [Abstract] [Full Text] [Related] Page: [Next] [New Search]